Phase IIa clinical study of [18F]fluciclovine: efficacy and safety of a new PET tracer for brain tumors
Crossref DOI link: https://doi.org/10.1007/s12149-016-1102-y
Published Online: 2016-07-14
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kondo, Akihide
Ishii, Hisato
Aoki, Shigeki
Suzuki, Masaru
Nagasawa, Hidekazu
Kubota, Kazuo
Minamimoto, Ryogo
Arakawa, Atsushi
Tominaga, Masato
Arai, Hajime
License valid from 2016-07-14